CCO Management Series
Research Priorities in Colorectal Cancer: Recommendations of the Scientific Leadership Council in GI Cancer of the Coalition of Cancer Cooperative Groups
Colorectal Cancer: Demographics and Screening |
Module 1 of 6 |
|
|
|
Dennis J. Ahnen, MD, reviews current and emerging screening techniques for colorectal cancer.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss current screening techniques for assessing colorectal cancer patients
- Describe novel biochemical and pharmacogenomic testing strategies for the detection and diagnosis of colorectal cancer
- Summarize key priorities for screening colorectal cancer patients
- List risk factors for the development of colorectal cancer
|
Colorectal Cancer Prevention |
Module 2 of 6 |
|
|
|
Axel Grothey, MD, reviews strategies to decrease the risk of colorectal cancer.
Learning Objectives
Upon completion of this activity, participants should be able to:
- List dietary and lifestyle factors known to decrease the risk of colorectal cancer
- Discuss the use of nonsteroidal antiinflammatory drugs for the prevention of colorectal cancer
- Describe the use of epigenetic alterations in the stratification of patients at risk for colorectal cancer
|
Colorectal Cancer Detection and Diagnosis |
Module 3 of 6 |
|
|
|
Heinz-Josef Lenz, MD, reviews modalities for the detection and imaging of colorectal cancer.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the use of computed tomography colonography in the detection and imaging of colorectal cancer
- Discuss the prognostic significance of tumor markers in patients with colorectal cancer
- Explain molecular imaging techniques in the assessment of therapeutic agents used to treat colorectal cancer
|
Adjuvant Treatment for Rectal Cancer |
Module 4 of 6 |
|
|
|
Joel E. Tepper, MD, reviews the current use of adjuvant chemotherapy for patients with rectal cancer
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe outcomes from different surgical techniques used for resection of early-stage rectal cancer
- Recall important unanswered questions in the adjuvant treatment of rectal cancer
- List current clinical trials for patients with rectal cancer
- Summarize recent clinical data regarding the use of targeted biologic therapy in the setting of rectal cancer
|
Adjuvant Treatment for Colon Cancer |
Module 5 of 6 |
|
|
|
Richard M. Goldberg, MD, reviews the current use of adjuvant chemotherapy for patients with colon cancer.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss recommendations for or against the use of adjuvant chemotherapy for patients with stage II colon cancer
- Describe current clinical trial data regarding adjuvant chemotherapy for patients with advanced colon cancer
- Summarize upcoming clinical trials of targeted therapies for the adjuvant treatment of colon cancer
|
Advanced Colorectal Cancer and Novel Therapies |
Module 6 of 6 |
|
|
|
Daniel G. Haller, MD, reviews the current treatment of advanced colorectal cancer and discusses emerging therapies.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe prognostic factors for patients with metastatic colorectal cancer
- Discuss efforts to overcome drug resistance in colorectal cancer
- Summarize studies of therapeutic approaches for patients with liver metastases from colorectal cancer
- Describe clinical trial results of targeted biologic agents for the treatment of metastatic colorectal cancer
|
Disclaimer:
The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
In association with
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|